Beyond omnichannel: Why pharma commercialisation must shift to omnideployment
The pharmaceutical industry has a deep-seated love affair with omnichannel. It is the word of the decade, dominating slides, agency pitches, and executive roundtables. Yet, if you sit down with five different commercial leaders and ask them what omnichannel actually means in practice, you will get five vastly different, often vague, answers. For too many…